Strategy, AI & Supply Chains: This Week in Healthcare

Nestlé, the world's largest food and beverage company, operates across 187 countries with a portfolio exceeding 2,000 brands.
This year the company convened its 159th Annual General Meeting in Lausanne, Switzerland, where shareholders approved the annual review detailing financial performance, business transformation and sustainability advancements.
The company's strategic direction increasingly emphasises health-focused innovation and nutritional advancement, positioning wellness at the core of its transformation strategy.
Merck & Co, known as MSD outside of the US and Canada, has entered a multi-year partnership with Google Cloud, aiming to transform its operations into an AI-enabled enterprise.
Valued at up to US$1bn, the collaboration is showing how large biopharmaceutical companies can integrate advanced technologies into their core infrastructure.
At the center of this initiative is the deployment of an agentic AI platform powered by tools such as Gemini Enterprise.
The goal is to modernise as well as accelerate innovation, productivity and patient impact across the healthcare ecosystem.
The pharmaceutical and life sciences industry is continuously being reshaped by sustainability goals alongside strict manufacturing and analytical performance requirements.
Advances in green chemistry and bio-based inputs are now influencing how essential laboratory materials are produced.
One of the latest developments in this space is Merck Group’s introduction of a bio-based solvent portfolio for high-performance liquid chromatography (HPLC).
This innovation reflects a broader shift toward reducing environmental impact without compromising precision in healthcare and pharmaceutical workflows.
“Global supply chains were built for cost, speed and scale, but not for resilience when health systems are under strain,” says the World Economic Forum (WEF).
From pandemics to climate-related disruptions and regional instability, these pressures are highlighting how closely workforce health is tied to economic continuity.
At the same time, access to healthcare and social protection has expanded more slowly than global trade and production systems.
As a result, workforce health is emerging as a structural risk embedded within global supply chains.
In a session at WEF’s Annual Meeting in Davos, leaders described “deep health protection gaps” across supply chains.
Healthcare facilities worldwide face mounting pressure to reduce their carbon footprint whilst maintaining the critical environments required for patient care.
According to the World Meteorological Organization, from 2023 to 2024 the global average concentration of COâ surged by 3.5 ppm, the largest increase since modern measurements started in 1957.
This escalating climate challenge has profound implications for the healthcare sector, which relies heavily on energy-intensive systems to maintain life-saving operations.
Johnson Controls, a global leader in decarbonisation, energy efficiency and thermal management, has released its 2026 Sustainability Report, highlighting the company's progress towards its sustainability targets and the measurable outcomes it is delivering across multiple sectors, including healthcare.
The report demonstrates how hospitals and medical facilities can achieve significant energy reductions without compromising the reliability essential for patient safety.








